ADVERSE-EFFECTS OF PROLONGED HYPERVENTILATION IN PATIENTS WITH SEVERE HEAD-INJURY - A RANDOMIZED CLINICAL-TRIAL

被引:683
|
作者
MUIZELAAR, JP
MARMAROU, A
WARD, JD
KONTOS, HA
CHOI, SC
BECKER, DP
GRUEMER, H
YOUNG, HF
机构
[1] Division of Neurosurgery, Medical College of Virginia, MCV Station Box 631, Richmond
关键词
HEAD INJURY; HYPERVENTILATION; TROMETHAMINE; OUTCOME; CEREBRAL BLOOD FLOW; INTRACRANIAL PRESSURE;
D O I
10.3171/jns.1991.75.5.0731
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is still controversy over whether or not patients should be hyperventilated after traumatic brain injury, and a randomized trial has never been conducted. The theoretical advantages of hyperventilation are cerebral vasoconstriction for intracranial pressure (ICP) control and reversal of brain and cerebrospinal fluid (CSF) acidosis. Possible disadvantages include cerebral vasoconstriction to such an extent that cerebral ischemia ensues, and only a short-lived effect on CSF pH with a loss of HCO3- buffer from CSF. The latter disadvantage might be overcome by the addition of the buffer tromethamine (THAM), which has shown some promise in experimental and clinical use. Accordingly, a trial was performed with patients randomly assigned to receive normal ventilation (PaCO2 35 +/- 2 mm Hg (mean +/- standard deviation): control group), hyperventilation (PaCO2 25 +/- 2 mm Hg: HV group), or hyperventilation plus THAM (PaCO2 25 +/- 2 mm Hg: HV + THAM group). Stratification into subgroups of patients with motor scores of 1-3 and 4-5 took place. Outcome was assessed according to the Glasgow Outcome Scale at 3, 6, and 12 months. There were 41 patients in the control group, 36 in the HV group, and 36 in the HV + THAM group. The mean Glasgow Coma Scale score for each group was 5.7 +/- 1.7, 5.6 +/- 1.7, and 5.9 +/- 1.7, respectively; this score and other indicators of severity of injury were not significantly different. A 100% follow-up review was obtained. At 3 and 6 months after injury the number of patients with a favorable outcome (good or moderately disabled) was significantly (p < 0.05) lower in the hyperventilated patients than in the control and HV + THAM groups. This occurred only in patients with a motor score of 4-5. At 12 months posttrauma this difference was not significant (p = 0. 13). Biochemical data indicated that hyperventilation could not sustain alkalinization in the CSF, although THAM could. Accordingly, cerebral blood flow (CBF) was lower in the HV + THAM group than in the control and HV groups, but neither CBF nor arteriovenous difference of oxygen data indicated the occurrence of cerebral ischemia in any of the three groups. Although mean ICP could be kept well below 25 mm Hg in all three groups, the course of ICP was most stable in the HV + THAM group. It is concluded that prophylactic hyperventilation is deleterious in head-injured patients with motor scores of 4-5. When sustained hyperventilation becomes necessary for ICP control, its deleterious effect may be overcome by the addition of THAM.
引用
收藏
页码:731 / 739
页数:9
相关论文
共 50 条
  • [1] STEROIDS IN SEVERE HEAD-INJURY - A PROSPECTIVE RANDOMIZED CLINICAL-TRIAL
    SAUL, TG
    DUCKER, TB
    SALCMAN, M
    CARRO, E
    [J]. JOURNAL OF NEUROSURGERY, 1981, 54 (05) : 596 - 600
  • [2] EFFECT OF THAM UPON OUTCOME IN SEVERE HEAD-INJURY - A RANDOMIZED PROSPECTIVE CLINICAL-TRIAL
    WOLF, AL
    LEVI, L
    MARMAROU, A
    WARD, JD
    MUIZELAAR, PJ
    CHOI, S
    YOUNG, H
    RIGAMONTI, D
    ROBINSON, WL
    [J]. JOURNAL OF NEUROSURGERY, 1993, 78 (01) : 54 - 59
  • [3] A CLINICAL-TRIAL OF TREATMENT FOR HYPOSMIA IN PATIENTS WITH HEAD-INJURY
    HENKIN, RI
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A460 - A460
  • [4] CIMETIDINE PREVENTION OF GASTROINTESTINAL BLEEDING IN SEVERE HEAD-INJURY - CONTROLLED CLINICAL-TRIAL
    HALLORAN, LG
    GAYLE, WE
    WHEELER, CB
    [J]. SURGICAL FORUM, 1978, 29 : 428 - 430
  • [5] TREATMENT OF PATIENTS WITH SEVERE HEAD-INJURY BY TRIAMCINOLONE - A PROSPECTIVE, CONTROLLED MULTICENTER CLINICAL-TRIAL OF 396 CASES
    GRUMME, T
    BAETHMANN, A
    KOLODZIEJCZYK, D
    KRIMMER, J
    FISCHER, M
    VONEISENHARTROTHE, B
    PELKA, R
    BENNEFELD, H
    POLLAUER, E
    KOSTRON, H
    LEHETA, F
    NECEK, S
    NEESER, G
    SACHSENHEIMER, W
    SOMMERAURER, J
    VERHOEVEN, F
    [J]. RESEARCH IN EXPERIMENTAL MEDICINE, 1995, 195 (04) : 217 - 229
  • [6] STEROIDS IN SEVERE HEAD-INJURY - A PROSPECTIVE RANDOMIZED TRIAL
    SAUL, TG
    DUCKER, TB
    SALCMAN, M
    CARRO, E
    [J]. CRITICAL CARE MEDICINE, 1981, 9 (03) : 152 - 152
  • [7] MEGADOSE STEROIDS IN SEVERE HEAD-INJURY - RESULTS OF A PROSPECTIVE DOUBLE-BLIND CLINICAL-TRIAL
    BRAAKMAN, R
    SCHOUTEN, HJA
    BLAAUWVANDISHOECK, M
    MINDERHOUD, JM
    [J]. JOURNAL OF NEUROSURGERY, 1983, 58 (03) : 326 - 330
  • [8] THE EFFECT OF HIGH-DOSE BARBITURATE DECOMPRESSION AFTER SEVERE HEAD-INJURY - A CONTROLLED CLINICAL-TRIAL
    NORDBY, HK
    NESBAKKEN, R
    [J]. ACTA NEUROCHIRURGICA, 1984, 72 (3-4) : 157 - 166
  • [9] CLINICAL ADVANCES IN MANAGEMENT OF PATIENTS WITH SEVERE HEAD-INJURY
    LANGFITT, TW
    [J]. MEDICAL COLLEGE OF VIRGINIA QUARTERLY, 1974, 10 (04): : 167 - 173
  • [10] A RANDOMIZED TRIAL OF NIMODIPINE IN SEVERE HEAD-INJURY - HIT-I
    TEASDALE, G
    BAILEY, I
    BELL, A
    GRAY, J
    GULLAN, R
    HEISKANAN, O
    MARKS, PV
    MARSH, H
    MENDELOW, DA
    MURRAY, G
    OHMAN, J
    QUAGHEBEUR, G
    SINAR, J
    SKENE, A
    TEASDALE, G
    WATERS, A
    [J]. JOURNAL OF NEUROTRAUMA, 1992, 9 : S545 - S550